REGULATION OF REAGINIC ANTIBODY RESPONSE

反应性抗体反应的调节

基本信息

  • 批准号:
    3124922
  • 负责人:
  • 金额:
    $ 24.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-02-01 至 1992-01-31
  • 项目状态:
    已结题

项目摘要

The purpose of this research is to elucidate the mechanisms involved in the regulation of the IgE response, and to find some maneuvors to suppress the IgE antibody formation to allergens. During the current grant period, we found that a lipocortin-like lymphokine, i.e., glycosylation inhibiting factor (GIF), suppressed the primary IgE and IgG antibody responses in the mouse, and diminished the on-going IgE antibody formation. Analysis of cellular mechanisms for the immunosuppression indicated that GIF facilitated the generation of antigen-specific suppressor T cells which formed their own GIF. In the present proposal, attempts will be made to generate antigen-specific suppressor T cells in vitro from antigen-primed T cells, and to elucidate the cellular and molecular mechanisms involved. Experiments will be carried out to determine whether GIF may change the function of antigen-primed T cells, and may affect the antigen-presenting cells. It was also shown that antigen-specific suppressor T cells form GIF which has affinity for the antigen, and that the antigen- specific GIF suppresses the in vivo antibody response in a carrier- specific manner. Mouse T cell hybridomas were constructed from an ovalbumin-primed mouse T cell clone. One of the T cell hybridomas form antigen-specific GIF upon incubation with antigen-pulsed syngenic macrophages. In this proposal, antigen- specific GIF will be obtained from the T cell hybridomas, and physicochemical properties of the molecules will be characterized. Comparisons will be made between the antigen- specific GIF and antigen-specific T suppressor factor (TsF) described by other investigators. Analysis will be made to determine whether the MHC compatibility between the cell source of antigen-specific GIF and target cells is essential for the carrier-specific suppression. Based on the findings obtained in mouse lymphocyte systems, attempts will be made to generate antigen-specific suppressor T cells in vitro from the peripheral blood T cells of allergic patients, and to construct human antigen- specific T cell hybridomas which will produce allergen-specific GIF that may suppress the antibody response to the allergen.
本研究的目的是阐明其机制

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A method to generate antigen-specific suppressor T cells in vitro from peripheral blood T cells of honey bee venom-sensitive, allergic patients.
一种从对蜂毒敏感、过敏的患者的外周血 T 细胞中体外生成抗原特异性抑制 T 细胞的方法。
  • DOI:
    10.1016/0022-1759(90)90072-4
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Carini,C;Iwata,M;Warner,J;Ishizaka,K
  • 通讯作者:
    Ishizaka,K
IL-4-producing murine T helper cell line provides help for in vitro production of IgE.
产生 IL-4 的鼠 T 辅助细胞系为 IgE 的体外生产提供帮助。
Lymphocytes bearing Fc receptor for IgE. VIII. Affinity of mouse IgE for Fc epsilon R on Mouse B lymphocytes.
携带 IgE Fc 受体的淋巴细胞。
Enhancement of mast cell differentiation in vitro by T cell factor(s).
T 细胞因子在体外增强肥大细胞分化。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIMISHIGE ISHIZAKA其他文献

KIMISHIGE ISHIZAKA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIMISHIGE ISHIZAKA', 18)}}的其他基金

SMALL INSTRUMENTATION GRANT
小型仪器补助金
  • 批准号:
    2073648
  • 财政年份:
    1994
  • 资助金额:
    $ 24.93万
  • 项目类别:
SMALL INSTRUMENTATION GRANT
小型仪器补助金
  • 批准号:
    3523669
  • 财政年份:
    1992
  • 资助金额:
    $ 24.93万
  • 项目类别:
BIOMEDICAL RESEARCH SUPPORT GRANT
生物医学研究资助
  • 批准号:
    3517636
  • 财政年份:
    1991
  • 资助金额:
    $ 24.93万
  • 项目类别:
ONTOGENY AND DIFFERENTIATION OF IGE-B-LYMPHOCYTES
IGE-B-淋巴细胞的个体发育和分化
  • 批准号:
    2060116
  • 财政年份:
    1989
  • 资助金额:
    $ 24.93万
  • 项目类别:
ONTOGENY AND DIFFERENTIATION OF IGE-B LYMPHOCYTES
IGE-B 淋巴细胞的个体发育和分化
  • 批准号:
    3480798
  • 财政年份:
    1989
  • 资助金额:
    $ 24.93万
  • 项目类别:
ONTOGENY AND DIFFERENTIATION OF IGE-B LYMPHOCYTES
IGE-B 淋巴细胞的个体发育和分化
  • 批准号:
    3480802
  • 财政年份:
    1989
  • 资助金额:
    $ 24.93万
  • 项目类别:
ONTOGENY AND DIFFERENTIATION OF IGE-B LYMPHOCYTES
IGE-B 淋巴细胞的个体发育和分化
  • 批准号:
    3480803
  • 财政年份:
    1989
  • 资助金额:
    $ 24.93万
  • 项目类别:
ONTOGENY AND DIFFERENTIATION OF IGE-B LYMPHOCYTES
IGE-B 淋巴细胞的个体发育和分化
  • 批准号:
    3480805
  • 财政年份:
    1989
  • 资助金额:
    $ 24.93万
  • 项目类别:
ONTOGENY AND DIFFERENTIATION OF IGE-B LYMPHOCYTES
IGE-B 淋巴细胞的个体发育和分化
  • 批准号:
    3480804
  • 财政年份:
    1989
  • 资助金额:
    $ 24.93万
  • 项目类别:
ONTOGENY AND DIFFERENTIATION OF IGE-B-LYMPHOCYTES
IGE-B-淋巴细胞的个体发育和分化
  • 批准号:
    2060117
  • 财政年份:
    1989
  • 资助金额:
    $ 24.93万
  • 项目类别:

相似海外基金

Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
  • 批准号:
    23H02361
  • 财政年份:
    2023
  • 资助金额:
    $ 24.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : GNT1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 24.93万
  • 项目类别:
    Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : 1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 24.93万
  • 项目类别:
    Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9300976
  • 财政年份:
    2015
  • 资助金额:
    $ 24.93万
  • 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9920805
  • 财政年份:
    2015
  • 资助金额:
    $ 24.93万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8900121
  • 财政年份:
    2012
  • 资助金额:
    $ 24.93万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8225814
  • 财政年份:
    2012
  • 资助金额:
    $ 24.93万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8699511
  • 财政年份:
    2012
  • 资助金额:
    $ 24.93万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8525355
  • 财政年份:
    2012
  • 资助金额:
    $ 24.93万
  • 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
  • 批准号:
    9115537
  • 财政年份:
    1991
  • 资助金额:
    $ 24.93万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了